AI assistant
Vijaya Diagnostic Centre Limited — Call Transcript 2025
May 6, 2025
59214_rns_2025-05-06_c11089d6-88c1-435c-98b7-fa136a002242.pdf
Call Transcript
Open in viewerOpens in your device viewer
==> picture [595 x 96] intentionally omitted <==
May 6, 2025
Listing Department National Stock Exchange of India Limited , NSE Symbol. VIJAYA
The Corporate Relations Department BSE Limited, BSE Scrip Code. 543350
Dear Sir/Madam,
Sub: Intimation of Analyst /Investor Earnings Conference call.
Pursuant to Regulation 30(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Company is hosting Earnings Conference call for analysts and investors on Monday, May 12, 2025, at 06:00 P.M. (IST) to discuss on the financials results of the Company for the fourth quarter and year ended March 31, 2025.
The dial-in details of the call are enclosed.
Please take the information on record.
Thanking you.
Yours faithfully, For Vijaya Diagnostic Centre Limited
Digitally signed by SUNIL SUNIL CHANDRA CHANDRA KONDAPALLY KONDAPALLY Date: 2025.05.06 17:45:31 +05'30'
Sunil Chandra Kondapally Whole-time Director DIN: 01409332
Encl.: As above
==> picture [612 x 72] intentionally omitted <==
JM Financial Institutional Securities invites you to the
==> picture [106 x 25] intentionally omitted <==
==> picture [85 x 10] intentionally omitted <==
----- Start of picture text ----- CORPORATE ACCESS----- End of picture text -----
==> picture [97 x 38] intentionally omitted <==
Q4 FY25 earnings conference call with
Vijaya Diagnostic Centre Ltd.
on Monday, 12[th] May 2025
06:00 PM IST | 08:30 AM USA EDT | 01:30 PM UK TIME | 08:30 PM HK/SINGAPORE TIME
Company Participants
Suprita Reddy
(Managing Director & Chief Executive Officer)
Sivaramaraju Vegesna
(Vice President – Operations)
Dhiren Gala
(Assistant General Manager – Strategy & Investor Relations)
Universal Dialin:
+91-22-6280 1366 / +91-22-7115 8267
Toll Free Number – International USA: UK: Singapore: Hong Kong: 1 866 746 2133 0 808 101 1573 800 101 2045 800 964 448
Please dial-in 10 minutes prior to the conference schedule to ensure that you are connected in time
Diamond Pass Link:
==> picture [188 x 39] intentionally omitted <==
For further information, please contact
Mr. Amey Chalke | +91-22-6630 3056 | [email protected] Mr. Raghav Vedanarayanan | +91-22-6224 1851 | [email protected]
JM Financial Institutional Securities Limited
Corporate Identity Number: U67100MH2017PLC296081 Member of BSE Ltd. and National Stock Exchange of India Ltd. SEBI Registration Nos.: Stock Broker - INZ000163434, Research Analyst - INH000000610 Registered Office: 7th Floor, Cnergy, Appasaheb Marathe Marg, Prabhadevi, Mumbai 400 025, India. Board: +9122 6630 3030 | Fax: +91 22 6630 3488 | Email: [email protected] | www.jmfl.com Compliance Officer: Mr. Sahil Salastekar | Tel: +91 22 6224 1073 | Email: [email protected] Grievance officer: Mr. Sahil Salastekar | Tel: +91 22 6224 1073 | Email: [email protected]
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Safe harbor:
The proposed management discussion and comments thereof may include forward-looking statements. Forward-looking statements are statements that concern plans, objectives, goals, strategies, future events or performance and underlying assumptions and other statements that are other than statements of historical fact. All forward looking statements are subject to risks, uncertainties and assumptions that could cause actual results of operations and financial conditions to differ materially from those contemplated by the relevant statement. All Conference Call Participants should not place undue reliance on these forward-looking statements. Registration granted by SEBI and certification from the National Institute of Securities Market (NISM) in no way guarantee performance of JM Financial Institutional Securities Limited or provide any assurance of returns to investors.